|
Merck Capital Ventures is a subsidiary of Merck & Co., Inc. founded
in November 2000. Merck Capital Ventures (MCV) actively invests in emerging
businesses with interesting technology in areas related to the
commercialization, distribution and delivery of pharmaceuticals and related
healthcare services.
The focus of MCV is to invest in technologies that accelerate innovation
related to the pharmaceutical business and other sectors of health care
delivery. While these new technologies have impacted some sectors of
healthcare, we are only at the very beginning of understanding and
capitalizing on the potential to transform many long-established processes
in the pharmaceutical industry and the health care field as a whole.
MCV is based in Woodcliff Lake, N.J.,
and is actively searching for investment opportunities. Investments are
typically in increments of $3MM-$8MM. This fund is not focused on investing
in research-based pharmaceutical, vaccine or biotechnology companies. Our
goal is to build a venture capital portfolio of promising emerging
companies that can bring added capabilities to Merck's core businesses and
generate attractive long-term investment returns.
About Merck
Merck & Co., Inc., is a leading research-driven pharmaceutical
products and services company. Merck discovers, develops, manufactures and
markets a broad range of innovative products to improve human and animal
health, directly and through its joint ventures.
|
